BOUT ETF top 10 holdings are 64.8% of the fund as of Aug 6, 2026

$44.33

AUM$16M

TER0.80%

Holdings48

See how much of BOUT you already own

Just $25 once·$69/mo·Download sample

X-ray my portfolio free

BOUT ETF top 10 holdings are 64.8% of the fund as of Aug 6, 2026

$44.33

CapForce IBD Breakout Opportunities ETF

AUM$16M

TER0.80%

Holdings48

See how much of BOUT you already own

Just $25 once·$69/mo·Download sample

X-ray my portfolio free

Overview Performance Chart Dividends Top Holdings All Holdings Sectors Geography Similar Compare Overlap

BOUT holds 64.8% of its assets in its 10 largest positions as of Aug 6, 2026. BOUT is CapForce IBD Breakout Opportunities ETF.

Showing the top 10 of 48 holdings · as of Aug 6, 2026

Top 10 weight

64.83%

BOUT top 10 holdings, by weight
#	Ticker	Name	Weight	Cumulative	Shares	Mkt value	Sector	Industry
1	ELVN	Enliven Therapeutics IncHealth Care · Biotechnology	7.62%	7.6%	20,461	$1.23M	Health Care	Biotechnology
2	GKOS	Glaukos Corp.Health Care · Healthcare Equip.	7.12%	14.7%	6,734	$1.15M	Health Care	Healthcare Equip.
Sector and industry · Pro
3	BCAX	Bicara Therapeutics, Inc.	7.04%	21.8%	41,391	$1.14M
4	USB	US Bancorp	7.02%	28.8%	17,801	$1.14M
5	—	Liquidia Technologies Inc	6.32%	35.1%	11,431	$1.02M
6	TPR	Tapestry Inc.	6.32%	41.4%	6,314	$1.02M
7	PNC	PNC Financial Services Group Inc.	6.01%	47.5%	3,850	$973.1K
8	OSCR	Oscar Health, Inc.	5.89%	53.3%	35,924	$953.4K
9	DAVE	Dave Inc	5.83%	59.2%	2,583	$943.5K
10	TGTX	Tg Therapeutics Inc	5.66%	64.8%	18,480	$915.7K
More holdings · Pro

FundXLS Pro

See the other 38 holdings of BOUT

X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.

Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

Themes in the top 10

BiotechnologyMedical DevicesOncologyImmunologyGlobal BankingDigital BankingLending & CreditPharmaceuticalsCardiologyBiotechnology ToolsLuxury GoodsConsumer SpendingMillennials & Gen ZInternet & DigitalDigital Advertising

BOUT ETF Top Holdings

BOUT holdings top 10 positions. The top 10 holdings account for 64.8% of the fund, led by Enliven Therapeutics Inc at 7.6%, Glaukos Corp. at 7.1%, Bicara Therapeutics, Inc. at 7.0%.

BOUT portfolio concentration is relatively high, with the top 10 representing 64.8% of total assets. The largest sector exposure is Financials at 39.0%.

BOUT sectors provide a detailed breakdown. BOUT overlap shows how holdings compare to other funds in your portfolio.

Compare BOUT

BOUT vs SPY BOUT vs QQQ BOUT vs VOO BOUT vs VTI BOUT vs IVV BOUT vs SCHD BOUT vs VYM BOUT vs VXUS

#	Ticker	Name	Industry	Weight
1	ELVN	Enliven Therapeutics Inc	Health Care	7.62%
2	GKOS	Glaukos Corp.	Health Care	7.12%
3	BCAX	Bicara Therapeutics, Inc.	Health Care	7.04%
4	USB	US Bancorp	Financials	7.02%
5	LQDA	Liquidia Technologies Inc	Health Care	6.32%
6	TPR	Tapestry Inc.	Consumer Discretionary	6.32%
7	PNC	Pnc Financial Services Group Inc.	Financials	6.01%
8	OSCR	Oscar Health, Inc.	Financials	5.89%
9	DAVE	Dave Inc Common Stock Usd.0001	Financials	5.83%
10	TGTX	Tg Therapeutics Inc Common Stock	Health Care	5.66%

BOUT ETF top 10 holdings are 64.8% of the fund as of Aug 6, 2026

BOUT ETF Top Holdings

Compare BOUT

Holdings Distribution